Private Equity

US

Real estate tech company Compass fetches $400 mln

New York City-based Compass, a real estate technology company, has raised $400 million in Series F financing. The Softbank Vision Fund and Qatar Investment Authority led the round with participation from Wellington, IVP and Fidelity.

1 min read · 27 September 2018

Arrowroot Capital targets $315 mln for fourth fund

Arrowroot Capital is seeking to raise $315 million for its fourth fund, according to an SEC filing. Santa Monica, California-based Arrowroot Capital Management is a growth equity firm that invests in B2B software firms.

1 min read · 27 September 2018

NovaQuest collects over $95 mln for fund

NovaQuest Capital Management has raised over $95 million for its debut private equity fund, according to an SEC filing. The target is $400 million. Based in Raleigh, North Carolina, NovaQuest invests in the life sciences and healthcare sector.

1 min read · 27 September 2018

Guardhat procures $20 mln Series A

Detroit-based Guardhat, an internet of things industrial safety technology developer, has raised $20 million in Series A funding. RTP Ventures led the round with participation from 3M Ventures, Caterpillar Venture Capital, Revolution's Rise of the Rest Seed Fund, SVB and DVP.

1 min read · 27 September 2018

VC-backed Sutro Biopharma debuts IPO

South San Francisco-based Sutro Biopharma Inc, a drug developer focused on creating protein therapeutics for cancer and autoimmune disorders, has raised about $85 million after pricing its over 5.6 million shares at $15 per share. The stock began trading September 27, 2018 on the NASDAQ under the ticker symbol "SRO." Cowen and Piper Jaffray are the lead underwriters. Also, Sutro has raised about $10 million in a private placement from Merck. Sutro's pre-IPO investors included Samsara BioCapital, Surveyor Capital, Alta Partners, Amgen Ventures, Celgene Corporation, Lilly Ventures, Skyline Ventures and SV Health Investors.

2 min read · 27 September 2018

VC-backed Arvinas goes public

New Haven, Connecticut-based Arvinas Inc, a biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases, has raised about $120 million after pricing its IPO of 7.5 million shares at $16 per share. The stock began trading September 27, 2018 on the NASDAQ under the ticker symbol “ARVN." Goldman Sachs, Citigroup and Piper Jaffray & Co are the lead underwriters. Arvinas' pre-IPO backers included Nextech Invest, Deerfield Management, Hillhouse Capital, Sirona Capital, Canaan Partners, 5AM Ventures, RA Capital Management, OrbiMed and New Leaf Venture Partners.

3 min read · 27 September 2018

Plant Prefab reels in $6.7 mln Series A

Rialto, California-based Plant Prefab, a home design and prefabrication company, has raised $6.7 million in Series A funding. The investors included Obvious Ventures and the Amazon Alexa Fund.

1 min read · 27 September 2018

Source Defense nets $10 mln Series A

Israel and Stamford, Connecticut-based Source Defense, a provider of prevention solutions for website supply-chain attacks, has raised $10 million in Series A funding. The investors were AllegisCyber, Jerusalem Venture Partners, Global Brain and Connecticut Innovations.

1 min read · 27 September 2018

Rally Rd snags $7 mln

Rally Rd, a tech platform that allows users to invest directly in rare alternative assets, has raised $7 million in funding. Upfront Ventures led the round with participation from other investors that included Anthemis Group and Social Leverage.

3 min read · 27 September 2018

Cargo garners $22 mln Series A

Cargo, a provider of in-car commerce for the ride-share economy, has secured $22 million in Series A financing. Founders Fund led the round with participation from other investors that included Coatue Management, Aquiline Technology Growth, former NBA Commissioner David Stern and Maria Shriver, journalist and former First Lady of California.

3 min read · 27 September 2018

Showing 6,621 to 6,630 of 41,792 results
1…662664…1000